Drug discontinuation: Gadoterate Meglumine Injection (GADOTERATE MEGLUMINE)
FDA lists 8 presentations as To Be Discontinued. Companies: Jiangsu Hengrui Pharmaceuticals Co., Ltd..
- Published by source
- 2026-05-21
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Products
- Gadoterate Meglumine Injection GADOTERATE MEGLUMINE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: To Be Discontinued
Remedy / actions:
- Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug
- Discontinuation of the manufacture of the drug
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2026-05-21
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #951 | new | 2026-10-22 | de6de6517eb8…21512f | 530ebb2d2b49…853bc0 |
Chain head: #1094 edf3be25ec2e…478842